Singleton-Merten syndrome kind 2 (SMS2) is an autosomal dominant, monogenic interferonopathy characterised by aortic calcification, skeletal abnormalities, and glaucoma. SMS2 is related to gain-of-function (GOF) variants in retinoic acid-inducible gene 1 (RIGI [previously known as DDX58]), an intracellular nucleic acid sensor that prompts manufacturing of kind I interferon on recognition of viral double-stranded RNA.1,2 Right here we characterize a novel RIGI variant in a younger affected person with SMS2 and describe our remedy expertise with anifrolumab, a mAb in opposition to the kind I interferon receptor.
Trending Merchandise
Added to wishlistRemoved from wishlist 0
$25.00
Added to wishlistRemoved from wishlist 0
$29.71
Added to wishlistRemoved from wishlist 0
$32.99
Added to wishlistRemoved from wishlist 0
$13.99
Added to wishlistRemoved from wishlist 0
$17.99
Added to wishlistRemoved from wishlist 0
$7.85
Added to wishlistRemoved from wishlist 0
$8.83
Added to wishlistRemoved from wishlist 0
$45.40
Added to wishlistRemoved from wishlist 0
$9.99
Carlyle Cat’s Claw Capsules 1000mg | 180 Count | Uncaria Tomentosa | Non-GMO, Gluten Free Supplement
Added to wishlistRemoved from wishlist 0
$15.28